Associated risk factors for silent cerebral infarcts in sickle cell anemia: Low baseline hemoglobin, sex, and relative high systolic blood pressure

Blood

Volumn 119, Issue 16, 2012, Pages 3684-3690

  DeBaun, Michael R ^a   Sarnaik, Sharada A ^b   Rodeghier, Mark J ^c   Minniti, Caterina P ^d   Howard, Thomas H ^e   Iyer, Rathi V ^f   Inusa, Baba ^g   Telfer, Paul T ^h   Kirby Allen, Melanie ⁱ   Quinn, Charles T ^j   Bernaudin, Françoise ^k   Airewele, Gladstone ^l   Woods, Gerald M ^m   Panepinto, Julie Ann ⁿ   Fuh, Beng ^o   Kwiatkowski, Janet K ^p   King, Allison A ^q   Rhodes, Melissa M ^r   Thompson, Alexis A ^s   Heiny, Mark E ^t   Redding Lallinger, Rupa C ^u   Kirkham, Fenella J ^v   Sabio, Hernan ^w   Gonzalez, Corina E ^x   Saccente, Suzanne L ^y   Kalinyak, Karen A ^j   Strouse, John J ^z   Fixler, Jason M ^aa   Gordon, Mae O ^q   Phillip Miller, J ^q   Noetzel, Michael J ^q   Ichord, Rebecca N ^p   Casella, James F ^z   more..

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Rodeghier Consultants   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^g EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^h ROYAL LONDON HOSPITAL   (United Kingdom)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^k CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

ⁿ MEDICAL COLLEGE OF WISCONSIN   (United States)

^o EAST CAROLINA UNIVERSITY   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r OHIO STATE UNIVERSITY   (United States)

^s NORTHWESTERN UNIVERSITY   (United States)

^t INDIANA UNIVERSITY   (United States)

^u UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY COLLEGE LONDON   (United Kingdom)

^w WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^x GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^y UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^z JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa SINAI HOSPITAL OF BALTIMORE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; ENALAPRIL; HEMOGLOBIN; LISINOPRIL;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BRAIN INFARCTION; CHILD; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SICKLE CELL ANEMIA; SILENT CEREBRAL INFARCTION; SYSTOLIC BLOOD PRESSURE;

EID: 84860328824     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-349621     Document Type: Article

References (33)

1. De Reuck J, Sieben G, De Coster W, vander Eecken H. Stroke pattern and topography of cerebral infarcts: a clinicopathological study. Eur Neurol. 1981;20(5):411-415. (Pubitemid 11017297)
2. Hindmarsh PC, Brozovic M, Brook CG, Davies SC. Incidence of overt and covert neurological damage in children with sickle cell disease. Postgrad Med J. 1987;63(743):751-753. (Pubitemid 17123594)
3. Glauser T, Lee B, Siegel M, DeBaun M. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy. J Child Neurol. 1995;10(2):88-92.
4. Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146(3):300-305.
5. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011; 117(4):1130-1140.
6. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014-3018. (Pubitemid 34525393)
7. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385-390. (Pubitemid 32889515)
8. Armstrong FD, Thompson RJ Jr, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease: Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996; 97(6):864-870. (Pubitemid 26170948)
9. DeBaun MR, Schatz J, Siegel MJ, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology. 1998;50(6): 1678-1682. (Pubitemid 28283234)
10. Bernaudin F, Verlhac S, Freard F, et al. Multi-center prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15(5):333-343. (Pubitemid 30341365)
11. Schatz J, Brown RT, Pascual JM, Hsu L, DeBaun MR. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology. 2001;56(8):1109-1111. (Pubitemid 32336325)
12. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999;103(3):640-645. (Pubitemid 29274513)
13. Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102(2):171-177. (Pubitemid 27122999)
14. Rodgers GP, Walker EC, Podgor MJ. Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease? Am J Med Sci. 1993;305(3):150-156. (Pubitemid 23098287)
15. Casella JF, King AA, Barton B, et al. Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol. 2010;27(2):69-89.
16. Vendt BA, McKinstry RC, Ball WS, et al. Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain. J Digit Imaging. 2009;22(3):326-343.
17. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol. 2008;83(1):15-18.
18. Hougaku H, Matsumoto M, Kitagawa K, et al. Silent cerebral infarction as a form of hypertensive target organ damage in the brain. Hypertension. 1992;20(6):816-820.
19. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33(1):21-25. (Pubitemid 34052178)
20. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis. 2004;44(1):35-41. (Pubitemid 38880924)
21. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost. 2010;8(1):54-59.
22. Zafeiriou DI, Prengler M, Gombakis N, et al. Central nervous system abnormalities in asymptomatic young patients with Sbeta-thalassemia. Ann Neurol. 2004;55(6):835-839. (Pubitemid 38702578)
23. Brass LM, Prohovnik I, Pavlakis SG, DeVivo DC, Piomelli S, Mohr JP. Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. Stroke. 1991;22(1):27-30.
24. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology. 1989;39(3):344-348. (Pubitemid 19094723)
25. Scothorn DJ, Price CL, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002; 140(3):348-354. (Pubitemid 34289713)
26. Wierenga KJ, Serjeant BE, Serjeant GR. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr. 2001;139(3):438-442. (Pubitemid 32889523)
27. Dowling MM, Quinn CT, Rogers ZR, Buchanan GR. Acute silent cerebral infarction in children with sickle cell anemia. Pediatr Blood Cancer. 2010;54(3):461-464.
28. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006; 107(6):2279-2285. (Pubitemid 43345545)
29. Kato GJ, Hsieh M, Machado R, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol. 2006;81(7):503-510.
30. Henderson JN, Noetzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood. 2003;101(2):415-419. (Pubitemid 36077557)
31. Brown AK, Sleeper LA, Miller ST, Pegelow CH, Gill FM, Waclawiw MA. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease: Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med. 1994;148(8):796-804. (Pubitemid 24243769)
32. Wang WC, Langston JW, Steen RG, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr. 1998;132(6):994-998. (Pubitemid 28280412)
33. Wang WC, Pavlakis SG, Helton KJ, et al. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer. 2008;51(5):643-646.